RNA, Viral

SEP 6, 2026 · JOURNAL ARTICLE

pgRNA-m6A levels associate with HBV replication and liver function.

Epigenetics

Mixed mechanistic and observational evidence from cell line and associational human studies without a controlled clinical trial, supporting a hypothesis about m6A modification in HBV but lacking efficacy data in patients.

AUG 9, 2026 · JOURNAL ARTICLE

Whole genome sequencing of unusual Hepatitis C virus subtypes and drug resistance analysis during direct-acting antiviral therapy in India.

Diagnostic Microbiology and Infectious Disease

First descriptive report of HCV genome sequencing and resistance patterns in an Indian cohort; uncontrolled, hospital-based study with small sample and no comparator arm, useful for surveillance but insufficient to guide treatment decisions.

AUG 3, 2026 · JOURNAL ARTICLE

Intranasal drop of multiplex RNA therapy for SARS-CoV-2 infections: baicalein-enhanced FEN1 nuclease cleaving as a virus buster.

Emerging Microbes & Infections

Early-stage in vivo study in mice using a novel intranasal nanomedicine formulation with a surrogate endpoint (viral load reduction), lacking control group details, clinical outcomes, and adequate sample size reporting.

FEB 3, 2026 · JOURNAL ARTICLE

HIV expression persists in the cerebrospinal fluid of HIV-associated neurocognitive disorders despite effective ART.

Emerging Microbes & Infections

Cross-sectional study showing HIV RNA and derived peptides persist in cerebrospinal fluid of HAND patients despite undetectable plasma viral load and adequate ART penetration, suggesting latent infection may drive neuroinflammation, but lacks comparator group and causal evidence.